Entyvio (vedolizumab) 300 mg powder for concentrate for solution for infusion, 1 vial (Takeda) Ulcerative colitis treatment. Drug delivery from Europe within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.
Display
- Treatment of active treatment of nonspecific viral colitis of mild and severe form in adult patients with adequate type, loss of type, or intolerance to standard therapy or necrosis factor antagonists puhlini alpha (FNP-?).
- Treatment of moderate and severe Crohn's disease in adult patients with adequate type, loss of type or intolerance to standard therapy or antagonists of puff necrosis factor alpha (FNP-?).
- Trade Name:Entivio
- Chemical Name:Vedolizumab
- Dosage:300 mg
- Quantity:1
- Form of Issue:Flacon
No reviews yet